Malti Patel

Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer

Jeff M. Michalski, Jennifer Moughan, James A. Purdy et al. · JAMA Oncology · 2018 · 358 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

Gillian Thomas, Shamshad Ali, Frank Hoebers et al. · Gynecologic Oncology · 2007 · 169 citations · Full text

Medicine, Hematology, Oncology +15

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study

David H. Miller, Robert J. Fox, J. Theodore Phillips et al. · Neurology · 2015 · 65 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Preliminary patient‐reported outcomes analysis of 3‐dimensional radiation therapy versus intensity‐modulated radiation therapy on the high‐dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial

Deborah Watkins Bruner, Daniel Hunt, Jeff M. Michalski et al. · Cancer · 2015 · 60 citations

Medicine, Oncology, Radiation Oncology +16